HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy

Current HIV Research

Volumn 8, Issue 4, 2010, Pages 336-339

  Costantini, Andrea ^a,b   Giuliodoro, Simona ^a   Butini, Luca ^b   Silvestri, Guido ^c   Leoni, Pietro ^a,b   Montroni, Maria ^a,b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antiretroviral therapy; CD34+ hematopoietic stem cells; CFU GM; HIV 1 infection; Myelopoiesis

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 3;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD34 SELECTION; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; HEMATOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMAGNETIC SEPARATION; MALE; MYELOPOIESIS; STEM CELL;

ADULT; ANTIGENS, CD34; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CELLS, CULTURED; CULTURE MEDIA; FEMALE; GRANULOCYTES; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MONOCYTES; MYELOID PROGENITOR CELLS; STEM CELLS;

EID: 77953533222     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016210791208604     Document Type: Article

References (15)

1. Moses A, Nelson J, Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 1998; 91: 1479-95.
2. Neal TF, Holland HK, Baum CM, et al. CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 1995; 86: 1749-56.
3. Weichold FF, Zella D, Barabitskaja O, et al. Neither human immunodeficiency virus-1 (HIV- 1) nor HIV-2 infects most- primitive human hematopoietic stem cells as assessed in long-term bone marrow culture. Blood 1998; 91: 907-15.
4. Koka PS, Jamieson BD, Brooks DG, Zack JA. Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo. J Virol 1999; 73: 9089-97.
5. Isgrò A, Aiuti A, Leti W, et al. Immunodysregulation of HIV disease at bone marrow level. Autimmun Rev 2005; 4: 486-90.
6. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services. October 10, 2006; 1-113. Available at http://www.aidsinfo.nih.gov/ Accessed 05 Oct 2009.
7. Costantini A, Giuliodoro S, Butini L, Silvestri G, Leoni P, Montroni M. Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. J AIDS 2009; 52: 70-74.
8. Isgrò A, Mezzaroma I, Aiuti A, et al. Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2000; 16: 1471-9.
9. Papadaki HA, Stamatopoulos K, Damianaki A, et al. Activated T- lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Br J Haematol 2005; 128: 863-76.
10. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004; 116: 639-48.
11. Kucia M, Ratajczak J, Ratajczak MZ. Are bone marrow stem cell plastic or heterogeneous - That is the question. Exp Hematol 2005; 33: 613-23.
12. Jansen J, Hanks S, Thompson JM, Dugan MJ, Akard LP. Transplantation of hematopoietic stem cells from the peripheral blood. J Cell Mol Med 2005; 9: 37-50.
13. Burt R, Pearce W, Luo K, et al. Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease. Bone Marrow Transplant 2003; 32(Suppl 1): S29-31.
14. Kawabata Y, Hirokawa M, Komatsuda A, Sawada K. Clinical applications of CD34+ cell-selected peripheral blood stem cells. Ther Apher Dial 2003; 7: 298-304.
15. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 192-7.